Please assess the completion status of the following clinical trial:

Trial Title: Real Life Assessment of Abilify Maintena

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria~* The patient must be 18 (19 for patients from British Columbia) years of age or older.~* The patient must have been diagnosed with schizophrenia.~* The patient must be at least mildly ill (CGI-S score of ≥3).~* The treating physician must have reached the decision to treat the patient with Abilify Maintena™ prior to and independently of soliciting the patient to participate in the study.~* The patient and legal guardian (if applicable and when allowable by law) must have signed an informed consent indicating the understanding of the study and allowing the use of their anonymous data for the purposes of the study.~* The patient and caregiver(s) (if applicable) must be fluent in English or French, in order to be able to complete the questionnaires.~Exclusion Criteria~* The patient does not comprehend or refuses to sign the informed consent.~* The patient has any contraindications to the use of Abilify Maintena™ as specified in the Canadian Product Monograph.~* The patient has previously received one or more doses of Abilify Maintena™.~* The patient presents a significant suicidal risk as judged by the investigator.~* The patient is a pregnant or lactating female.~* The patient is a member of the study personnel or of their immediate families, or is a subordinate (or immediate family member of a subordinate) to any of the study personnel.~* The patient has previously been enrolled in this study.~* The patient is, in the investigator's opinion, unlikely to comply with the protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).